In addition, subgroup analysis of the high PD-L1 expression NSCLC cohort in KEYNOTE 407 confirmed the effectiveness of immune checkpoint inhibitors combined with chemotherapy (chemo-ICI) [5]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.